semaglutide health risks South Africa's regulator is reviewing 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisk's blockbuster diabetes and weight-loss medicines Ozempic and Wegovy, it said on Tuesday. Novo's Ozempic Study Finds Mental Health
Pay in 4 interest-free payments of $7.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21




























